Salvatore Crisafulli

About Salvatore Crisafulli

Salvatore Crisafulli, With an exceptional h-index of 15 and a recent h-index of 15 (since 2020), a distinguished researcher at Università degli Studi di Messina, specializes in the field of Pharmacoepidemiology, Pharmacovigilance, Pharmacology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Medication review and deprescribing in different healthcare settings: a position statement from an Italian scientific consortium

Epidemiological analysis to identify predictors of X-linked hypophosphatemia (XLH) diagnosis in an Italian pediatric population: the EPIX project

Artificial intelligence for optimizing benefits and minimizing risks of pharmacological therapies: challenges and opportunities

Machine learning-based algorithms applied to drug prescriptions and other healthcare services in the Sicilian claims database to identify acromegaly as a model for the earlier …

Exploring the level of agreement among different drug-drug interaction checkers: a comparative study on direct oral anticoagulants

Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems

Myasthenia Gravis Treatment: From Old Drugs to Innovative Therapies with a Glimpse into the Future

Is antidepressant use a concern for patients with COPD?

Salvatore Crisafulli Information

University

Position

___

Citations(all)

1299

Citations(since 2020)

1282

Cited By

202

hIndex(all)

15

hIndex(since 2020)

15

i10Index(all)

19

i10Index(since 2020)

19

Email

University Profile Page

Google Scholar

Salvatore Crisafulli Skills & Research Interests

Pharmacoepidemiology

Pharmacovigilance

Pharmacology

Top articles of Salvatore Crisafulli

Medication review and deprescribing in different healthcare settings: a position statement from an Italian scientific consortium

2024/12

Epidemiological analysis to identify predictors of X-linked hypophosphatemia (XLH) diagnosis in an Italian pediatric population: the EPIX project

Endocrine

2024/4/9

Salvatore Crisafulli
Salvatore Crisafulli

H-Index: 9

Artificial intelligence for optimizing benefits and minimizing risks of pharmacological therapies: challenges and opportunities

2024/3/18

Salvatore Crisafulli
Salvatore Crisafulli

H-Index: 9

Machine learning-based algorithms applied to drug prescriptions and other healthcare services in the Sicilian claims database to identify acromegaly as a model for the earlier …

Scientific Reports

2024/3/14

Salvatore Crisafulli
Salvatore Crisafulli

H-Index: 9

Carlo Combi
Carlo Combi

H-Index: 19

Exploring the level of agreement among different drug-drug interaction checkers: a comparative study on direct oral anticoagulants

2024/2/24

Salvatore Crisafulli
Salvatore Crisafulli

H-Index: 9

Giuseppe Andò
Giuseppe Andò

H-Index: 20

Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems

2024/1/26

Daniele Sartori
Daniele Sartori

H-Index: 7

Salvatore Crisafulli
Salvatore Crisafulli

H-Index: 9

Myasthenia Gravis Treatment: From Old Drugs to Innovative Therapies with a Glimpse into the Future

2024/1/11

Salvatore Crisafulli
Salvatore Crisafulli

H-Index: 9

Is antidepressant use a concern for patients with COPD?

2024/1/1

Salvatore Crisafulli
Salvatore Crisafulli

H-Index: 9

The pharmacological treatment of granulomatosis with polyangiitis: a review of clinical trials registered in clinicaltrials. gov and the International Clinical Trials Registry …

2023/12

Effectiveness of homologous/heterologous booster COVID-19 vaccination schedules against severe illness in general population and clinical subgroups in three European countries

Vaccine

2023/11/13

Felipe Villalobos
Felipe Villalobos

H-Index: 9

Salvatore Crisafulli
Salvatore Crisafulli

H-Index: 9

Pharmacological Therapies of Spinal Muscular Atrophy: A Narrative Review of Preclinical, Clinical–Experimental, and Real-World Evidence

2023/10/10

Salvatore Crisafulli
Salvatore Crisafulli

H-Index: 9

Global incidence and prevalence of differentiated thyroid cancer in childhood: systematic review and meta-analysis

2023/9/19

An overview of methodological flaws of real-world studies investigating drug safety in the post-marketing setting

2023/5/4

Salvatore Crisafulli
Salvatore Crisafulli

H-Index: 9

Zakir Khan
Zakir Khan

H-Index: 7

Yusuf Karatas
Yusuf Karatas

H-Index: 10

Is PEGylation of drugs associated with hypersensitivity reactions? An analysis of the Italian national spontaneous adverse drug reaction reporting system

Drug Safety

2023/4

Salvatore Crisafulli
Salvatore Crisafulli

H-Index: 9

Paola Minghetti
Paola Minghetti

H-Index: 25

Assessing intravitreal anti-VEGF drug safety using real-world data: methodological challenges in observational research

2022/2/1

Real-world evidence and pharmacovigilance: workshop of the Italian Epidemiological Association and of the Italian Society of Pharmacology

EPIDEMIOLOGIA E PREVENZIONE

2022

Deprescribing as a strategy for improving safety of medicines in older people: Clinical and regulatory perspective

Frontiers in Drug Safety and Regulation

2022

Development and testing of diagnostic algorithms to identify patients with acromegaly in Southern Italian claims databases

Scientific Reports

2022/9/23

Salvatore Crisafulli
Salvatore Crisafulli

H-Index: 9

Janet Sultana
Janet Sultana

H-Index: 11

Drug-induced urinary retention: an analysis of a national spontaneous adverse drug reaction reporting database

European Urology Focus

2022/9/1

Salvatore Crisafulli
Salvatore Crisafulli

H-Index: 9

The role of real-world evidence for the study of rare diseases epidemiology and the post-marketing evaluation of orphan drugs.

Recenti Progressi in Medicina

2022/7/1

Salvatore Crisafulli
Salvatore Crisafulli

H-Index: 9

See List of Professors in Salvatore Crisafulli University(Università degli Studi di Messina)